India’s approval of its first dengue vaccine provides an vital new device to the nation’s response to a persistent public-health problem. The Central Medicine Normal Management Organisation has granted advertising authorisation for a stay attenuated tetravalent dengue vaccine for people aged 4-60 years. The approval deserves recognition, but it surely shouldn’t be interpreted because the arrival of a stand-alone answer. Dengue is formed by the interplay of the virus, the mosquito, the surroundings, human behaviour and the capability of well being methods to detect and handle illness. The vaccine’s actual worth will subsequently depend upon how nicely it’s included into an built-in dengue prevention and administration technique.
The size of the problem explains why a further preventive device issues. The World Well being Group estimates that 100-400 million dengue infections happen yearly, whereas greater than half of the world’s inhabitants is now in danger. In 2024, nations reported greater than 14.4 million instances, over 52,000 extreme instances and 11,201 deaths–the highest international transmission recorded up to now. India’s official surveillance system recorded 233,519 instances and 297 deaths in 2024, after 289,235 instances and 485 deaths in 2023. These are reported instances and don’t seize the total burden of delicate, asymptomatic, undiagnosed or privately handled infections.
India is very susceptible as a result of dengue is endemic throughout a lot of the nation, all 4 viral serotypes flow into, and recurrent outbreaks have an effect on each densely populated cities and increasing peri-urban and rural areas. A current assessment described India as carrying a disproportionately excessive share of the worldwide dengue burden. Local weather-based modelling means that by the 2050s, roughly 1.5 billion individuals in India could possibly be residing in areas environmentally appropriate for dengue transmission. Such projections usually are not forecasts of precise sickness, however they underline how quickly the geography of danger might increase.
Dengue is tough to regulate by way of any single intervention. An infection with one serotype usually supplies long-term safety in opposition to that serotype however not in opposition to the opposite three; a later an infection with a unique serotype could also be related to the next danger of extreme illness. On the similar time, Aedes aegypti has tailored remarkably nicely to city life. It breeds in small collections of water round houses, development websites, markets, establishments and public areas, and it could actually maintain transmission even the place periodic fogging or spraying is undertaken. Fast urbanisation, water-storage practices, weak solid-waste administration, mobility, altering rainfall and temperature patterns, and insecticide resistance all affect transmission.
The vaccine can add a priceless layer of safety, significantly by lowering symptomatic illness and hospitalisation. Within the pivotal part 3 trial involving greater than 20,000 youngsters and adolescents aged 4-16 years in dengue-endemic nations, vaccine efficacy was 80.2% in opposition to virologically confirmed dengue throughout the major evaluation interval and 90.4% in opposition to hospitalised dengue over the secondary endpoint interval. Longer follow-up confirmed cumulative efficacy of 62.1% in opposition to symptomatic dengue and 84.1% in opposition to hospitalised dengue over 4.5 years. These outcomes are encouraging, however in addition they present why vaccine efficiency shouldn’t be decreased to a single headline determine: efficacy modified over time and diverse by serotype, age and former dengue publicity.
Regulatory approval and public-programme introduction are, subsequently, totally different choices. Approval establishes {that a} vaccine meets the regulator’s necessities for high quality, security and efficacy for its authorised indication. A call to introduce it by way of a public programme should moreover take into account the nation’s age-specific illness burden, native seroprevalence and serotype patterns, length of safety, impression on hospitalisation and extreme illness, cost-effectiveness, affordability, provide, supply capability, fairness and post-introduction security monitoring. WHO presently recommends programmatic use of this vaccine in youngsters aged 6-16 years in settings with excessive dengue transmission depth, utilizing two doses three months aside. It additionally states that vaccination ought to type a part of an built-in dengue-control technique and doesn’t stop all instances.
Operational feasibility is a crucial consideration when assessing whether or not a vaccine is appropriate for inclusion in a public-health programme. The flexibility to manage the dengue vaccine with out particular person pre-vaccination serological testing removes a big implementation barrier. In a rustic of India’s dimension and variety, population-wide screening earlier than vaccination would add substantial value, time and logistical complexity, significantly in areas with restricted laboratory capability.
This benefit, nevertheless, shouldn’t be interpreted as eliminating the necessity for epidemiological evaluation. Choices on programme introduction should nonetheless be guided by native dengue burden, transmission depth, circulating serotypes, age-specific proof, affordability, cost-effectiveness and the capability to finish the two-dose schedule and monitor security. The absence of particular person testing, subsequently, makes supply extra possible, however it’s only certainly one of a number of concerns that ought to decide whether or not, the place and amongst whom vaccination is launched.
For India, built-in dengue administration ought to start with stronger surveillance. Case reporting, laboratory affirmation, hospital admissions, circulating serotypes, vector density, climate and native environmental situations should be introduced collectively at district and metropolis degree. Surveillance shouldn’t merely depend instances after an outbreak has begun; it ought to assist early warning, determine high-risk neighbourhoods and information the timing and depth of interventions. Higher estimates of age-specific seroprevalence and hospitalisation would additionally assist decide the place vaccination may generate the best public-health worth.
Vector management stays indispensable. The emphasis should transfer from episodic, extremely seen responses throughout outbreaks to sustained supply discount all year long. City native our bodies, well being departments, housing societies, faculties, workplaces, development companies and communities all have a task. Common removing or masking of water containers, administration of discarded tyres and strong waste, inspection of development websites, improved drainage, protected water-storage practices and focused larval management are more practical when carried out constantly and domestically. Insecticide use ought to be guided by entomological surveillance and resistance knowledge somewhat than relied upon as a routine substitute for environmental administration.
Medical preparedness is equally vital. There’s nonetheless no particular antiviral remedy for dengue, however early recognition, right triage, cautious fluid administration, well timed referral and monitoring for warning indicators can considerably scale back preventable deaths. Major-care amenities and emergency departments want normal protocols, educated groups, satisfactory diagnostics, referral linkages and surge plans earlier than the seasonal rise in instances. Public communication ought to assist individuals recognise warning indicators and search care promptly, whereas additionally discouraging pointless platelet transfusions, irrational antibiotic use and self-medication with medication which will enhance bleeding danger.
Group participation can’t be handled as a seasonal consciousness marketing campaign. As a result of many breeding websites are situated in and round houses and workplaces, family and institutional motion is central to dengue prevention. Communication ought to be sensible, repeated and domestically tailored: what residents ought to examine, how regularly they need to do it, when to hunt care, and why fogging alone can not defend a group. Engagement is extra more likely to be sustained when municipalities present dependable waste assortment, water provide, drainage and responsive grievance mechanisms alongside behaviour-change messages.
The vaccine ought to be launched with the identical self-discipline. India may use burden, seroprevalence and hospitalisation knowledge to determine high-transmission settings, assess focused introduction, monitor effectiveness beneath native situations and construct strong adverse-event surveillance. As a result of anaphylaxis and different uncommon occasions might grow to be seen solely after large-scale use, vaccination websites should have educated employees, commentary protocols and the capability to handle acute reactions. Clear communication about advantages, limitations and uncertainties can be important for public confidence.
The central coverage message is subsequently simple: the vaccine is an addition, not a substitute. It can not compensate for delayed case detection, fragmented surveillance, poor city providers, weak vector management or insufficient scientific preparedness. Nor ought to its arrival divert sources from the foundational measures that defend individuals of all ages, together with those that might not be eligible for vaccination.
India’s first dengue vaccine can mark a brand new chapter–but provided that it catalyses a stronger total response. Success shouldn’t be measured just by the variety of doses administered. Fewer infections, fewer hospitalisations, fewer deaths, earlier outbreak detection, better-managed city environments and higher group participation ought to measure it. Vaccination, surveillance, vector management, environmental administration, scientific care and public engagement should function as one built-in system. That’s how a promising scientific advance may be translated into sturdy public-health progress.
(The views expressed are private)
This text is authored by Dr Okay Madan Gopal, senior well being sector professional and former senior marketing consultant, well being, NITI Aayog.
